IVISense MMP 750 FAST Fluorescent Probe (MMPSense)
IVISense MMP 750 FAST Fluorescent Probe (MMPSense)
Matrix metalloproteinases (MMPs) are calcium-dependent zinc containing endopeptidases responsible for the degradation of most of extracellular matrix proteins during organogenesis, growth and normal tissue turnover. MMPs play a role in almost every biological cell process from embryo implantation to cell death and have been implicated in a wide range of diseases including inflammation, arthritis, pulmonary disease, cancer and more.
Revvity’s IVISense™ MMP NIR activatable fluorescence probes (MMPSense®) are designed to evaluate many disease related processes including cancer progression, rheumatoid arthritis, pulmonary disease and more as well as evaluating therapeutic efficacy of potential drug candidates.
For research use only. Not for use in diagnostic procedures.
| Feature | Specification |
|---|---|
| Unit Size | 1 Vial (10 doses) |
Matrix metalloproteinases (MMPs) are calcium-dependent zinc containing endopeptidases responsible for the degradation of most of extracellular matrix proteins during organogenesis, growth and normal tissue turnover. MMPs play a role in almost every biological cell process from embryo implantation to cell death and have been implicated in a wide range of diseases including inflammation, arthritis, pulmonary disease, cancer and more.
Revvity’s IVISense™ MMP NIR activatable fluorescence probes (MMPSense®) are designed to evaluate many disease related processes including cancer progression, rheumatoid arthritis, pulmonary disease and more as well as evaluating therapeutic efficacy of potential drug candidates.
For research use only. Not for use in diagnostic procedures.
IVISense MMP 750 FAST Fluorescent Probe (MMPSense)
IVISense MMP 750 FAST Fluorescent Probe (MMPSense)
Product information
Overview
IVISense MMP 750 FAST is excited by 749 nm excitation light, and emits at 775 nm. MMP 750 FAST is a member of a family of activatable fluorescent imaging agents comprising a novel architecture termed F.A.S.T. (Fluorescent Activatable Sensor Technology), that allows for an earlier optimal imaging window of 12-24 hours after injection, facilitating detection of MMP activity changes in acute models of inflammation or stroke. In addition, the 750 nm wavelength is optimal for minimizing the impact of autofluorescence and chow-related fluorescence that can interfere with image quality. Including IVISense MMP 750 FAST in careful experimental design allows for multiplexing with other channels and/or imaging times, and so can be paired with other probes to achieve maximum efficiency and flexibility in imaging.
Specifications
| Brand |
IVISense
|
|---|---|
| Fluorescent Agent Type |
Activatable
|
| Imaging Modality |
Fluorescence
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Therapeutic Area |
Arthritis
Atherosclerosis
Inflammation
Oncology/Cancer
|
| Unit Size |
1 Vial (10 doses)
|
| Wave Length |
750 nm
|
Resources
Are you looking for resources, click on the resource type to explore further.
Fluorescence molecular imaging is the visualization of cellular and biological function in vivo to gain deeper insights into...
SDS, COAs, Manuals and more
Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.
-
言語English国EU
-
言語English国United States
-
Lot numberANYLot dateSeptember 6, 2023名前
Related products
How can we help you?
We are here to answer your questions.
